Pharma & Biotech

Soleno Therapeutics finds itself navigating turbulent waters after reports emerged of a patient fatality connected to its lead drug candidate,...

Indian pharmaceutical giant Dr. Reddy's Laboratories finds itself balancing on a strategic tightrope. The company is simultaneously addressing significant regulatory...

Despite boasting a promising development pipeline and solid financial metrics, Arcus Biosciences shares are confronting significant valuation challenges. The biopharmaceutical...

The investment landscape surrounding healthcare distributor McKesson presents a fascinating divergence of opinion. While major institutional players are building significant...

A puzzling divergence is capturing investor attention in the biotech sector. Biomarin Pharmaceutical Inc., a company delivering groundbreaking therapies and...

The Cooper Companies' latest quarterly earnings have placed its shares under the microscope. While the medical device manufacturer demonstrated solid...

Despite announcing a series of significant clinical breakthroughs and maintaining a robust financial position, BioNTech SE shares experienced notable downward...

Vertex Pharmaceuticals presents investors with a compelling puzzle. The biotechnology giant continues to deliver robust financial performance and clinical breakthroughs,...

A significant policy development from the U.S. Food and Drug Administration (FDA) is creating a favorable environment for companies developing...

The telehealth provider Hims & Hers finds itself navigating turbulent regulatory waters. Its recent expansion into the multi-billion dollar testosterone...